Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01072526 · ClinicalTrials.gov registry record · Phase 2

Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease

A Phase 2 study, sponsored by University of Missouri-Columbia.

Terminated
Registry status
Phase 2
Development phase
7
Enrollment target

NCT01072526: Clinical Trial Phase 2 study, sponsored by University of Missouri-Columbia.

NCT01072526 is a Phase 2 study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 7 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01072526, a Phase 2 study, was terminated before completion, sponsored by University of Missouri-Columbia.

TERMINATED
Registry status
Phase 2
Development phase
7 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether a homeopathic therapy in combination with cyclosporin (Restasis) is more effective than cyclosporin (Restasis) alone in the treatment of dry eye disease.

Primary Outcome

Measures dry eye disease and effect on vision-related function. Measured on a scale of 0-100, with higher scores indicating greater disability.

Interventions

  • DRUG Euphrasia-based homeopathic therapy
  • DRUG Cyclosporin solution

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2007-12
Est. Completion 2010-08
Phase Phase 2
University of Missouri-Columbia

291 total trials

Why NCT01072526 stopped before completion

NCT01072526 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Euphrasia-based homeopathic therapy is the first listed.

NCT01072526 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01072526 about?

NCT01072526 is a clinical study titled "Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease". The purpose of this study is to determine whether a homeopathic therapy in combination with cyclosporin (Restasis) is more effective than cyclosporin (Restasis) alone in the treatment of dry eye disease.

What is the current status of trial NCT01072526?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2007-12. Estimated completion is 2010-08.

What interventions are being tested in trial NCT01072526?

The interventions under investigation include: Euphrasia-based homeopathic therapy (DRUG), Cyclosporin solution (DRUG).

Who is sponsoring clinical trial NCT01072526?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01072526's enrollment target sits among peer trials

7 1996th of 2000 higher than 5 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01072526, the US trial registry maintained by the National Library of Medicine. NCT01072526 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.